Eczema Patients Treated with Upadacitinib in Real World Setting See Significant Improvements

This late-breaking data featured at RAD 2024 highlights several improvements in patient reported outcomes observed among atopic dermatitis patients, including itch relief.

Related Keywords

Chicago ,Illinois ,United States ,Jonathan Silverberg ,Drug Administration ,George Washington University School Of Medicine ,Health Sciences ,Revolutionizing Atopic Dermatitis ,Clinically Relevant Patient Reported Outcomes ,Long Term Effectiveness ,Atopic Dermatitis ,George Washington University ,